#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Christopher Ozeroff Email
SVP/General Counsel . ARCA biopharma
How to contact Christopher Ozeroff
Join and see Christopher's contact info for free!Current Roles
Employees:
25Revenue:
$3.5MAbout
ARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA biopharma began operations in 2005 and is headquartered in Broomfield, Colorado. The Company’s lead investigational product is Gencaro™ 1 (bucindolol hydrochloride), a genetically-targeted beta-blocker with unique pharmacology, in development for heart failure and other indications. ARCA’s New Drug Application for Gencaro for chronic heart failure, was accepted for filing by the U.S. Food and Drug Administration in September, 2008, and is currently under review by the FDA with a Prescription Drug User Fee Act (PDUFA) date of May 31, 2009.ARCA biopharma Address
11080 Circlepoint RdBroomfield, CO
United States